BAYER AKTIENGESELLSCHAFT Insider Profile
4 Followers
BAYER AKTIENGESELLSCHAFT, Ten Percent Owner at Century Therapeutics, holds 12.68M shares in Century Therapeutics (Ticker: IPSC), holds 5.71M shares in Crispr Therapeutics AG (Ticker: CRSP).
BAYER AKTIENGESELLSCHAFT's Trading History
You May Also Like
BAYER AKTIENGESELLSCHAFT insider profile FAQ
What is the percentage of profitable transactions made by BAYER AKTIENGESELLSCHAFT?
The percentage of profitable transactions made by BAYER AKTIENGESELLSCHAFT is 0%.
What is the average return per transaction made by BAYER AKTIENGESELLSCHAFT?
The average return per transaction made by BAYER AKTIENGESELLSCHAFT is -42.30%.
What stocks does BAYER AKTIENGESELLSCHAFT hold?
BAYER AKTIENGESELLSCHAFT holds: IPSC, CRSP stocks.
What was BAYER AKTIENGESELLSCHAFT's most profitable transaction?
BAYER AKTIENGESELLSCHAFT’s most profitable transaction was an Informative Buy of CRSP stock on January 30, 2018. The return on the trade was -22.60%.
What is BAYER AKTIENGESELLSCHAFT's role in Century Therapeutics?
BAYER AKTIENGESELLSCHAFT's role in Century Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
